Researchers from Charité – Universitätsmedizin Berlin have shown that antibiotics can increase the risk of some types of pneumonia by weakening the lung’s immune system. Findings suggest that this risk may be reduced through the administration of…
German diagnostics company sphingotec GmbH (Hennigsdorf) and Nexus Dx (San Diego) have combined their technology platforms to market sphingotec’s CE-marked acute biomarkers penKid® and bio-ADM® on Nexus’ market-validated POC testing immunoassay…
Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) are pleased to announce that ‘The Virtual Brain’ neuroinformatics platform has joined the EU’s Flagship ‘Human Brain Project’. With financial support from the EU’s Horizon…
The Leonidas Zervas Award is presented in commemoration of his outstanding contributions to peptide science. The award is given to the scientist who has made the most outstanding contributions to the chemistry, biochemistry and/or biology of…
On 5 July 2018, CO.DON AG has signed a letter of intent (LOI) with Xintela AB, Lund (Sweden), by which the two companies have agreed to start negotiations regarding the establishment of a joint venture for the development and commercialization of…
Emmanuelle Charpentier, director at the Max Planck Institute for Infection Biology in Berlin, is among the winners of the internationally renowned Kavli prize. She is honoured for her pioneering work in developing the CRISPR-Cas9 system, a…
ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, and Pionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor…
RaySearch, a medical technology company for innovative software solutions, and Eckert & Ziegler BEBIG have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare oncology information system will be integrated…
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has issued another tranche of the ODIRNANE bonds (undated bonds…
With a new blood test, researchers at the Charité – Universitätsmedizin Berlin can determine the state of the internal clock of a person. Once the internal rhythm of patient is known, drugs could be administered at particular times of day making them…
